Washington State House of Representatives Office of Program Research | BILL ANALYSIS |
Health Care & Wellness Committee |
HB 1765
This analysis was prepared by non-partisan legislative staff for the use of legislative members in their deliberations. This analysis is not a part of the legislation nor does it constitute a statement of legislative intent. |
Brief Description: Concerning donations to the prescription drug donation program.
Sponsors: Representatives Irwin, Koster, Volz, Kraft, Stokesbary and Kloba.
Brief Summary of Bill |
|
Hearing Date: 2/3/17
Staff: Jim Morishima (786-7191).
Background:
A pharmacy may not accept for return prescription drugs after they have been taken from the premises where sold, distributed, or dispensed, except for under limited circumstances. For example, a pharmacy may accept for return drugs legally dispensed by prescription in unit dose forms or in sealed single- or multiple-dose ampoules or vials where the pharmacist can readily determine that entry or attempted entry has not been made and which meet United States Pharmacopeia for storage conditions. A pharmacy may also accept controlled substances for purposes of destruction.
Under the Prescription Drug Donation Program, a practitioner, pharmacist, medical facility, drug manufacturer, or drug wholesaler may donate prescription drugs and supplies to a pharmacy for redistribution without compensation. When redistributing donated drugs, priority is given to patients who are uninsured and have an income of 200 percent of the federal poverty level or less. A drug may only be donated if it was stored under required temperature conditions using the drug's time/temperature indicator information and the donor has completed and signed a donor form to release the drug for distribution and certifying that the drug has never been opened, used, adulterated, or misbranded.
Summary of Bill:
To be eligible for donation, only drugs equipped with a time/temperature indicator at the point of manufacture must be stored under required temperature conditions using the drugs' time/temperature indicator information.
Appropriation: None.
Fiscal Note: Not requested.
Effective Date: The bill takes effect 90 days after adjournment of the session in which the bill is passed.